DE69719083T2 - Neuartige orale Zubereitungen von Calcitonin - Google Patents

Neuartige orale Zubereitungen von Calcitonin

Info

Publication number
DE69719083T2
DE69719083T2 DE69719083T DE69719083T DE69719083T2 DE 69719083 T2 DE69719083 T2 DE 69719083T2 DE 69719083 T DE69719083 T DE 69719083T DE 69719083 T DE69719083 T DE 69719083T DE 69719083 T2 DE69719083 T2 DE 69719083T2
Authority
DE
Germany
Prior art keywords
calcitonin
oral preparations
novel oral
novel
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69719083T
Other languages
English (en)
Other versions
DE69719083D1 (de
Inventor
Matteo Ghirri
Marco Zema
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adare Pharmaceuticals SRL
Original Assignee
Eurand International SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurand International SpA filed Critical Eurand International SpA
Publication of DE69719083D1 publication Critical patent/DE69719083D1/de
Application granted granted Critical
Publication of DE69719083T2 publication Critical patent/DE69719083T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
DE69719083T 1996-11-07 1997-11-05 Neuartige orale Zubereitungen von Calcitonin Expired - Fee Related DE69719083T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9623205.3A GB9623205D0 (en) 1996-11-07 1996-11-07 Novel pharmaceutical compositions
PCT/EP1997/006104 WO1998019697A2 (en) 1996-11-07 1997-11-05 Novel pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE69719083D1 DE69719083D1 (de) 2003-03-20
DE69719083T2 true DE69719083T2 (de) 2003-12-18

Family

ID=10802593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69719083T Expired - Fee Related DE69719083T2 (de) 1996-11-07 1997-11-05 Neuartige orale Zubereitungen von Calcitonin

Country Status (15)

Country Link
US (1) US6352974B1 (de)
EP (1) EP0966299B1 (de)
JP (1) JP2001511114A (de)
AR (1) AR010554A1 (de)
AT (1) ATE232397T1 (de)
AU (1) AU5317598A (de)
CA (1) CA2270927A1 (de)
CO (1) CO4930284A1 (de)
DE (1) DE69719083T2 (de)
DK (1) DK0966299T3 (de)
ES (1) ES2192704T3 (de)
GB (1) GB9623205D0 (de)
PT (1) PT966299E (de)
WO (1) WO1998019697A2 (de)
ZA (1) ZA9710006B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000054797A2 (en) 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
EP1274720A4 (de) * 2000-04-12 2004-08-18 Human Genome Sciences Inc Albumin enthaltende fusionsproteine
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
PL1651249T3 (pl) * 2003-07-23 2013-04-30 Novartis Ag Zastosowanie kalcytoniny w zapaleniu kości i stawów
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7581403B2 (en) * 2005-04-15 2009-09-01 Deeks Daniel H Energy storage arrangement
AU2006236006B2 (en) * 2006-04-13 2012-09-06 The University Of Queensland Cyclised a-conotoxin peptides
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090117180A1 (en) * 2007-02-20 2009-05-07 Giovanni Ortenzi Stable digestive enzyme compositions
CN103933555B (zh) * 2007-02-20 2018-06-01 阿普塔利斯制药有限公司 稳定的消化酶组合物
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
AR093181A1 (es) 2010-10-01 2015-05-27 Aptalis Pharmatech Inc Formulacion con contenido de enzimas digestivas bajo estable
ES2558756T3 (es) 2011-08-08 2016-02-08 Aptalis Pharma Limited Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
RU2679832C2 (ru) 2013-08-09 2019-02-13 Аллерган Фармасьютикалз Интернэйшнл Лимитед Композиция пищеварительных ферментов, подходящая для энтерального введения
CA2947998A1 (en) 2014-06-19 2015-12-23 Aptalis Pharma Ltd. Methods for removing viral contaminants from pancreatic extracts

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
JP2514249B2 (ja) * 1989-05-23 1996-07-10 帝人株式会社 安定化されたカルシトニン類医薬組成物
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
JPH08225454A (ja) * 1995-02-23 1996-09-03 Chugai Pharmaceut Co Ltd マイクロスフェア製剤

Also Published As

Publication number Publication date
AR010554A1 (es) 2000-06-28
US6352974B1 (en) 2002-03-05
CA2270927A1 (en) 1998-05-14
EP0966299A2 (de) 1999-12-29
AU5317598A (en) 1998-05-29
ES2192704T3 (es) 2003-10-16
GB9623205D0 (en) 1997-01-08
DK0966299T3 (da) 2003-06-02
ATE232397T1 (de) 2003-02-15
WO1998019697A3 (en) 1998-07-16
WO1998019697A2 (en) 1998-05-14
DE69719083D1 (de) 2003-03-20
JP2001511114A (ja) 2001-08-07
CO4930284A1 (es) 2000-06-27
PT966299E (pt) 2003-06-30
EP0966299B1 (de) 2003-02-12
ZA9710006B (en) 1999-06-05

Similar Documents

Publication Publication Date Title
DE19681287T1 (de) Orale Formulierung von 2-Methylthienobenzodiazepin
DE69429359D1 (de) Orale zubereitungen von antimykotika
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
ATE253371T1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE69833739D1 (de) Kosmetisches Präparat
DE69518331D1 (de) Orale zubereitungen
KR950703926A (ko) 화장제 조성물(Cosmetic Composition)
DE69625368T2 (de) Schweisshemmende deodorierende präparaten
DE69329764D1 (de) Neues kosmetisches präparat
DE69528131T2 (de) Kosmetische Präparate
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ATE176383T1 (de) Dermal applizierbare formulierungen von parasitiziden
DE59710701D1 (de) Kosmetische zubereitungen
DE69804630D1 (de) Reindarstellung von propylenoxid
DE69415340T2 (de) Kosmetisches präparat
DE59804418D1 (de) Kosmetische zubereitungen
DE69719083T2 (de) Neuartige orale Zubereitungen von Calcitonin
DE69720546D1 (de) Kaskadierter Anschluss von kommuniziernden Geräten
KR970000228A (ko) S-에토돌락의 경구용 제제
DE59709718D1 (de) Kosmetische zubereitungen
DE69518464D1 (de) Verdickte kosmetische Zubereitungen
DE59707298D1 (de) Desodorierende zubereitungen
DE69432149D1 (de) Orale Zubereitungen
DE69733607D1 (de) Herstellung von cycloalkyldiarylphosphinen
DE69737529D1 (de) Herstellung von 1-butyl-4-piperidinylmethylamin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee